Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12612000209897
ACTRN12612000209897
Completed
Phase 1

Pharmacological actions and clinical evaluation of a Chinese Herbal formula in the treatment of seasonal allergic rhinitis: A double blind, randomized, placebo-controlled trial.

Professor Charlie Xua0 sites104 target enrollmentFebruary 20, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsseasonal allergic rhinitisInflammatory and Immune System - AllergiesRespiratory - Other respiratory disorders / diseasesAlternative and Complementary Medicine - Herbal remedies

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
seasonal allergic rhinitis
Sponsor
Professor Charlie Xua
Enrollment
104
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 20, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Professor Charlie Xua

Eligibility Criteria

Inclusion Criteria

  • •(a) age between 18 to 65 years with two or more symptoms for at least two years with a total nasal symptom score (TNSS) of at least six;
  • •(b) a positive pollen skin prick test (SPT).

Exclusion Criteria

  • •(a) initiated immunotherapy since last SAR season;
  • •(b) HIV positive;
  • •(c) other active respiratory disease within 30 days of study; (d) receiving oral corticosteroid treatment;
  • •(e) pregnancy or lactation;
  • •(f) nasal polyposis; and
  • •(g) unable to read or understand English.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical efficacy, saftey and pharmacodynamics of antifungal agents on chronic pulmonary mycosis
JPRN-UMIN000003108ational Hospital Organization, Tokyo National Hospital20
Not yet recruiting
Not Applicable
To study the effect of â??Dashemani Kandughna Gelâ?? local application in the management of Dandruff ( itching over scalp, Flakes on scalp etc)Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
CTRI/2020/12/030010Dr Nilima Sanjay Dharkar
Active, not recruiting
Phase 1
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.
EUCTR2012-005127-33-BEniversity Ghent20
Active, not recruiting
Not Applicable
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. - NDbipolar disordersMedDRA version: 9.1Level: LLTClassification code 10057667Term: Bipolar disorder
EUCTR2008-000370-20-ITAZIENDA OSPEDALIERA PISANA
Active, not recruiting
Not Applicable
Pharmacodynamic and clinical evaluation of dose and taste-optimised low volume PEG-based bowel cleansing solutions using the split-dosing intake regimen in healthy subjects and in subjects undergoing screening colonoscopyBowel cleansing prior to colonoscopyMedDRA version: 14.1Level: PTClassification code 10066943Term: Bowel preparationSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]
EUCTR2012-003052-37-DEorgine Ltd